{"id":"W3100094353","doi":"10.1212/wnl.0000000000011108","title":"Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis","year":2020,"lang":"en","type":"article","venue":"Neurology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Grifols; Baxalta; CSL Behring; Argenx; Biogen; Alnylam Pharmaceuticals; UCB Pharma; Alexion Pharmaceuticals; Pfizer","keywords":"Medicine; Placebo; Myasthenia gravis; Adverse effect; Randomized controlled trial; Clinical endpoint; Confidence interval; Internal medicine; Anesthesia; Gastroenterology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00156316,0.000669038,0.001782524,0.000196916,0.0002191188,0.0004815185,0.0004157624,0.0007971293,0.00220997],"category_scores_gemma":[0.001193863,0.0002869991,0.0008932247,0.0001587365,0.0006524638,0.0004545468,0.0002096509,0.001414675,0.0003510428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003784863,"about_ca_system_score_gemma":0.0005397113,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003133941,"about_ca_topic_score_gemma":0.0009119175,"domain_scores_codex":[0.9993863,0.0003697822,0.00005053246,0.00007207871,0.00005549853,0.00006574969],"domain_scores_gemma":[0.999334,0.0002025757,0.0002184451,0.00004584316,0.000029905,0.0001691841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7441005,0.01841672,0.008438008,0.001984085,0.001662164,0.0002654486,0.0001510055,0.001229401,0.07255919,0.0002078894,0.001340744,0.1496449],"study_design_scores_gemma":[0.5321385,0.434768,0.02645131,0.00009538673,0.0006635852,0.0004104116,0.00004426856,0.0006105616,0.003373932,0.0001164253,0.001306372,0.00002121255],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932053,0.004688025,0.0002532303,0.000274837,0.00005979278,0.0004903842,0.0001724649,0.0000353992,0.0008206193],"genre_scores_gemma":[0.9972939,0.001093224,0.0004079237,0.0002742112,0.0001131983,0.0003109034,0.0001732499,0.00000450221,0.0003289978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00220997,"threshold_uncertainty_score":0.008266866,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01829010272296743,"score_gpt":0.2550515880254441,"score_spread":0.2367614853024767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}